K.J. Harrison & Partners Inc Hillstream Bio Pharma Inc. Transaction History

K.J. Harrison & Partners Inc

  • $610 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
SELL
$0.67 - $1.51 $15,678 - $35,334
-23,400 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$1.16 - $4.1 $27,143 - $95,939
23,400 New
23,400 $37,000

About Hillstream BioPharma Inc.

HILS Quotes by TradingView
  • Ticker HILS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,529,900
  • Market Cap $33.2M
  • Description
  • Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...
More about HILS
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email